Mendoza Evelyn F MD is categorized under Hematologists in Sun City, CA and active since 2007.
Mendoza Evelyn F MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Evelyn Mendoza at the company’s single location by writing to 28400 Mccall Boulevard, Sun City, California CA 92585 or by phoning (951) 301-7812. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mendoza Evelyn F MD |
| Contact Person: | Evelyn Mendoza |
| Address: | 28400 Mccall Boulevard, Sun City, California 92585 |
| Phone Number: | (951) 301-7812 |
| Website Address: | hematologyoncologyconsultants.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mendoza Evelyn F MD was started in 2007 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Evelyn Mendoza for inquiries that concern Mendoza Evelyn F MD by calling the company number (951) 301-7812, as your correspondence is most welcome. Additionally, the physical location of the single location of Mendoza Evelyn F MD can be found at the coordinates 33.72008,-117.16342 as well as the street address 28400 Mccall Boulevard in Sun City, California 92585.
For its online presence, you may visit Mendoza Evelyn F MD’s website at hematologyoncologyconsultants.com and engage with its social media outlets through on Twitter and on Facebook.